Adaptin Bio (APTN) Operating Expenses (2023 - 2026)

Adaptin Bio has disclosed Operating Expenses across 4 years of filings, most recently posting $1.2 million for Q2 2026.

• In Q2 2026, Operating Expenses fell 21.06% year-over-year to $1.2 million; the TTM figure through Jun 2026 stood at $5.4 million (up 39.09% YoY), while the FY2025 annual figure was $5.4 million, up 110.71% from the prior year.
• Operating Expenses came in at $1.2 million for Q2 2026 at Adaptin Bio, up from $1.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.7 million in Q3 2025 to a low of $34155.0 in Q4 2023.
• Average Operating Expenses over 4 years is $867224.2, with a median of $922603.5 recorded in 2024.
• Year-over-year, Operating Expenses soared 2216.71% in 2024 and decreased 21.06% in 2026.
• Over 4 years, Operating Expenses stood at $34155.0 in 2023, then soared by 1387.57% to $508080.0 in 2024, then jumped by 169.25% to $1.4 million in 2025, then declined by 12.24% to $1.2 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $1.2 million in Q2 2026, $1.1 million in Q1 2026, and $1.4 million in Q4 2025.